221 related articles for article (PubMed ID: 17127041)
1. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.
de Oliveira Silva C; Delbosc S; Araïs C; Monnier L; Cristol JP; Pares-Herbute N
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):23-30. PubMed ID: 17127041
[TBL] [Abstract][Full Text] [Related]
2. Apocynin decreases AGEs-induced stimulation of NF-κB protein expression in vascular smooth muscle cells from GK rats.
Silva CO; da Silva OA; Duarte GP; Descomps B; Lahlou S
Pharm Biol; 2015 Apr; 53(4):488-93. PubMed ID: 25471209
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells.
Kwok CF; Juan CC; Ho LT
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E648-52. PubMed ID: 16985264
[TBL] [Abstract][Full Text] [Related]
5. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.
Xanthis A; Hatzitolios A; Fidani S; Befani C; Giannakoulas G; Koliakos G
Angiology; 2009 Dec-2010 Jan; 60(6):772-9. PubMed ID: 19190027
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
7. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
8. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
10. Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation.
Liu X; Luo D; Zheng M; Hao Y; Hou L; Zhang S
Eur J Pharmacol; 2010 Mar; 629(1-3):153-8. PubMed ID: 20004657
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.
Dadke SS; Li HC; Kusari AB; Begum N; Kusari J
Biochem Biophys Res Commun; 2000 Aug; 274(3):583-9. PubMed ID: 10924321
[TBL] [Abstract][Full Text] [Related]
12. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
Hodgkinson CP; Laxton RC; Patel K; Ye S
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats.
Rodríguez A; Frühbeck G; Gómez-Ambrosi J; Catalán V; Sáinz N; Díez J; Zalba G; Fortuño A
J Hypertens; 2006 Aug; 24(8):1589-97. PubMed ID: 16877962
[TBL] [Abstract][Full Text] [Related]
19. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
Sun M; Yokoyama M; Ishiwata T; Asano G
Int J Exp Pathol; 1998 Aug; 79(4):207-22. PubMed ID: 9797717
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
